Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 3
2008 3
2009 1
2012 1
2015 2
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
Tong XM, Zhang SY, Song T, Xu WH, Lin XN, Shu J, Liu L. Tong XM, et al. Chin Med J (Engl). 2008 Dec 5;121(23):2434-9. Chin Med J (Engl). 2008. PMID: 19102964
Gonadotropin-releasing hormone antagonists (GnRHanta) are thought to be effective in preventing this complication, and some clinical trials have found lower incidences of OHSS in patients treated with GnRHanta. Our aim was to investigate the
Gonadotropin-releasing hormone antagonists (GnRHanta) are thought to be effective in preventing this comp
Expression of GnRH receptor in the canine corpus luteum, and luteal function following deslorelin acetate-induced puberty delay.
Kaya D, Gram A, Kowalewski MP, Schäfer-Somi S, Kuru M, Boos A, Aslan S. Kaya D, et al. Reprod Domest Anim. 2017 Dec;52(6):1104-1112. doi: 10.1111/rda.13038. Epub 2017 Sep 30. Reprod Domest Anim. 2017. PMID: 28963736
The goals of this study were as follows: (Experiment 1) to examine the basic capability of canine corpora lutea (CL) to respond to GnRH by assessing expression of gonadotropin-releasing hormone receptor (GnRH-R) in luteal samples collected throu …
The goals of this study were as follows: (Experiment 1) to examine the basic capability of canine corpora lutea (CL) to respond to GnRH by a …
Expression of anti-Mullerian hormone protein during early follicular development in the primate ovary in vivo is influenced by suppression of gonadotropin secretion and inhibition of vascular endothelial growth factor.
Thomas FH, Telfer EE, Fraser HM. Thomas FH, et al. Endocrinology. 2007 May;148(5):2273-81. doi: 10.1210/en.2006-1501. Epub 2007 Feb 22. Endocrinology. 2007. PMID: 17317775
Anti-Mullerian hormone (AMH) plays a role during early follicular development and selection. The aim of this study was to determine the pattern of AMH protein expression in the marmoset ovary and to investigate the effects of inhibition of gonadotropins or …
Anti-Mullerian hormone (AMH) plays a role during early follicular development and selection. The aim of this study was to determine t …
Reducing the Risk of OHSS by GnRH Agonist Triggering.
Casper RF. Casper RF. J Clin Endocrinol Metab. 2015 Dec;100(12):4396-8. doi: 10.1210/jc.2015-3676. Epub 2015 Oct 29. J Clin Endocrinol Metab. 2015. PMID: 26513003
There is evidence that administration of GnRH agonist as the trigger for final follicular maturation, instead of the usual human chorionic gonadotropin trigger, will reduce the risk of OHSS by shortening the duration of luteal stimulation, lowering estrogen levels by induc …
There is evidence that administration of GnRH agonist as the trigger for final follicular maturation, instead of the usual human chorionic …
Urinary gonadotrophins but not recombinant gonadotrophins reduce expression of VEGF120 and its receptors flt-1 and flk-1 in the mouse uterus during the peri-implantation period.
Sibug RM, de Koning J, Tijssen AM, de Ruiter MC, de Kloet ER, Helmerhorst FM. Sibug RM, et al. Hum Reprod. 2005 Mar;20(3):649-56. doi: 10.1093/humrep/deh648. Epub 2004 Dec 9. Hum Reprod. 2005. PMID: 15591083
The effects of the gonadotrophins on the expression of vascular endothelial growth factor120 (VEG120) and its receptors and the corticotrophin releasing hormone (CRH) system during the peri-implantation period were studied. …
The effects of the gonadotrophins on the expression of vascular endothelial growth factor120 (VEG120) and …
Oestrogen and progesterone receptors in the marmoset endometrium: changes during the ovulatory cycle, early pregnancy and after inhibition of vascular endothelial growth factor, GnRH or ovariectomy.
Silvestri A, Fraser HM. Silvestri A, et al. Reproduction. 2007 Aug;134(2):341-53. doi: 10.1530/REP-06-0266. Reproduction. 2007. PMID: 17660243
These receptors were localised and semi-quantitatively analysed throughout the ovulatory cycle, weeks 2, 3 and 4 of pregnancy and after treatment with GnRH antagonist, vascular endothelial growth factor (VEGF) Trap or ovariectomy. ...E
These receptors were localised and semi-quantitatively analysed throughout the ovulatory cycle, weeks 2, 3 and 4 of pregnancy and aft …
GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
Miller I, Chuderland D, Ron-El R, Shalgi R, Ben-Ami I. Miller I, et al. J Clin Endocrinol Metab. 2015 Nov;100(11):E1428-36. doi: 10.1210/jc.2015-2312. Epub 2015 Aug 26. J Clin Endocrinol Metab. 2015. PMID: 26308290
We have shown that ovarian pigment epithelium derived factor (PEDF), a potent antiangiogenic factor, counteracts vascular endothelial growth factor (VEGF) expression and that OHSS is correlated with hCG-induced impaired PEDF to VEG …
We have shown that ovarian pigment epithelium derived factor (PEDF), a potent antiangiogenic factor, counteracts vascular
Cumulus cells gene expression profiling in terms of oocyte maturity in controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist.
Devjak R, Fon Tacer K, Juvan P, Virant Klun I, Rozman D, Vrtačnik Bokal E. Devjak R, et al. PLoS One. 2012;7(10):e47106. doi: 10.1371/journal.pone.0047106. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082142 Free PMC article. Clinical Trial.
In in vitro fertilization (IVF) cycles controlled ovarian hyperstimulation (COH) is established by gonadotropins in combination with gonadotropin-releasing hormone (GnRH) agonists or antagonists, to prevent premature luteinizing hormone (LH) sur …
In in vitro fertilization (IVF) cycles controlled ovarian hyperstimulation (COH) is established by gonadotropins in combination with gona
Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs.
Parborell F, Irusta G, Rodríguez Celín A, Tesone M. Parborell F, et al. Mol Reprod Dev. 2008 Apr;75(4):623-31. doi: 10.1002/mrd.20806. Mol Reprod Dev. 2008. PMID: 17874466
An adequate vascular supply is important to provide endocrine and paracrine signals during follicular development. We evaluated the direct in vivo effects of both the GnRH-agonist Leuprolide acetate (LA) and the GnRH-antagonist Antide (Ant) on the expressi
An adequate vascular supply is important to provide endocrine and paracrine signals during follicular development. We evaluated the d …
Targeted drug and gene delivery systems for lung cancer therapy.
Sundaram S, Trivedi R, Durairaj C, Ramesh R, Ambati BK, Kompella UB. Sundaram S, et al. Clin Cancer Res. 2009 Dec 1;15(23):7299-308. doi: 10.1158/1078-0432.CCR-09-1745. Epub 2009 Nov 17. Clin Cancer Res. 2009. PMID: 19920099 Free PMC article.
PURPOSE: To evaluate the efficacy of a novel docetaxel derivative of deslorelin, a luteinizing hormone-releasing hormone (LHRH) agonist, and its combination in vivo with RGD peptide conjugated nanoparticles encapsulating an antiangiogenic, anti-vascular
PURPOSE: To evaluate the efficacy of a novel docetaxel derivative of deslorelin, a luteinizing hormone-releasing hormone
11 results
Jump to page
Feedback